Related Experiment Video
Updated: Jan 17, 2026

A Mouse Model of Ankle-Subtalar Complex Joint Instability
Published on: October 28, 2022
PATHOGENESIS OF ACUTE DIABETIC CHARCOT ARTHROPATHY IN THE FOOT AND ANKLE: A COMPREHENSIVE LITERATURE REVIEW
Osama Embaby1, Afdhal Bin Asmadi2, Aiman Binte Asmadi2
1Trauma and Orthopedics Sandwell & West Birmingham Hospitals NHS Trust.
Insights
Acute Diabetic Charcot Arthropathy (ADCA) is a severe diabetes complication. Early diagnosis and intervention are crucial for managing this condition and improving patient mobility.
Area of Science:
- Endocrinology and Metabolism
- Rheumatology
- Diabetic Complications
Background:
- Acute Diabetic Charcot Arthropathy (ADCA) is a severe complication of diabetes mellitus, frequently misdiagnosed.
- Peripheral neuropathy in diabetic patients increases susceptibility to ADCA.
- ADCA shares clinical similarities with cellulitis and deep vein thrombosis, complicating early diagnosis.
Purpose of the Study:
- To review the pathophysiology of ADCA, focusing on early diagnostic markers.
- To explore the role of inflammatory cytokines and signaling pathways in ADCA progression.
- To discuss the impact of metabolic factors and comorbidities on ADCA development.
Main Methods:
- Literature review of ADCA pathophysiology, diagnosis, and management.
- Analysis of inflammatory cytokine roles (TNF-α, IL-1β, IL-6) in bone and joint degeneration.
- Investigation of Wnt and IL-17 signaling pathways as potential therapeutic targets.
Main Results:
- ADCA is a complex condition driven by neuropathy, inflammation, and metabolic dysregulation.
- Inflammatory cytokines significantly contribute to bone loss and joint damage in ADCA.
- Wnt and IL-17 signaling pathways present potential targets for novel ADCA therapies.
Conclusions:
- Early diagnosis and intervention are critical for preventing ADCA progression and improving patient outcomes.
- A comprehensive management strategy, including stress reduction and patient education, is essential.
- Advances in clinical practice and research integration are vital for enhancing ADCA treatment.
Abstract:
Acute Diabetic Charcot Arthropathy (ADCA) is a severe complication of diabetes mellitus in patients with peripheral neuropathy, often misdiagnosed due to its similarity to cellulitis or deep vein thrombosis. This review examines ADCA's pathophysiology, emphasizing early diagnosis to prevent progression. We explore the roles of inflammatory cytokines (TNF-α, IL-1β, IL-6) in bone loss and joint degeneration, and investigate potential biomarkers and therapeutic targets in Wnt and IL-17 signaling pathways. The impact of metabolic imbalances and comorbidities on ADCA development is also discussed. Our analysis reveals ADCA's complex, multifactorial nature, involving neuropathy, inflammatory responses, and metabolic dysregulation. A comprehensive management approach aimed at achieving a stable, ulcer-free foot is essential to improve patient mobility and quality of life. We conclude that early intervention is crucial, focusing on reducing stress on affected regions in inflammatory stages. This is achieved by highlighting and implementing the advances in clinical practice, integration of recent research, education of patients on the importance of early intervention alongside developing improvements to current treatments.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Ankle Joint

